TY  - JOUR
TI  - In-Cell Western Protocol for Semi-High-Throughput Screening of Single Clones
AU  - Pal, Arpita S
AU  - Agredo Montealegre, Alejandra 
AU  - Kasinski, Andrea L. 
VL  - 12
IS  - 16
PY  - 2022
DA  - 2022/08/20
SP  - e4489
C1  - Bio-protocol 2022;12:e4489
DO  - 10.21769/BioProtoc.4489
UR  - https://doi.org/10.21769/BioProtoc.4489
AB  - The in-cell western (ICW) is an immunocytochemical technique that has been used to screen for effects of siRNAs, drugs, and small molecule inhibitors. The reduced time and number of cells required to follow this protocol illustrates its semi-high-throughput nature. Performing a successful ICW protocol requires fixing and permeabilizing adherent cells directly in the plate that specifically exposes the epitope of interest. After blocking of non-specific proteins, the cells are incubated overnight with a primary antibody of interest, which is detected via a host-specific near-infrared fluorescently labeled LI-COR secondary antibody. In the final step, the plate is scanned using an Odyssey LI-COR Imaging System or similar, and each of the wells is quantified. For the first time, this technique has been demonstrated to be reproducibly utilized for semi-high-throughput selection of knockout or overexpression clones.Graphical abstract:
KW  - In-cell western
KW  - Single clone selection
KW  - Knockout
KW  - Overexpression
KW  - Doxycycline
KW  - High-throughput
KW  - LI-COR
KW  - CRISPR-Cas9
KW  - Screen validation
JF  - Bio-protocol
SN  - 2331-8325
PB  - Bio-protocol LLC.
BIO101  - False